Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 5/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 5/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | DCUN1D1 | Q96GG9 | 2/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | UBE2M | P61081 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19680105 | 0.78 | AKR1C3 (0.50) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL19779319 | 0.78 | AKR1C3 (0.50) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL21488823 | 0.78 | AKR1C3 (0.58) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL17517023 | 0.77 | AKR1C3 (0.67) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL19680103 | 0.76 | AKR1C3 (0.49) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL3123627 | 0.75 | IDO1 (0.61) | IDO1KDRMEN1ALDH1A1AR | |
| SCHEMBL1966415 | 0.75 | KDM1A (0.48) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL1633802 | 0.75 | ALDH1A1 (0.58) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL21488709 | 0.72 | AKR1C3 (0.53) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 | |
| SCHEMBL30645447 | 0.72 | AKR1C3 (0.53) | AKR1C3AKR1C2PTGS1PTGS2TAS2R14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9868701-B2 | Method for producing nitrogen-containing pentafluorosulfanylbenzene compound | UBE INDUSTRIES, LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
| US-20170349545-A1 | METHOD FOR PRODUCING NITROGEN-CONTAINING PENTAFLUOROSULFANYLBENZENE COMPOUND | UBE CORPORATION (JP) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349545-A1 | METHOD FOR PRODUCING NITROGEN-CONTAINING PENTAFLUOROSULFANYLBENZENE COMPOUND | NPM1, PYM1, FPR2 | AKR1C3 1630/4885AKR1C2 2794/4885PTGS1 2916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.